Illuminating the CKD patient journey: Clinicogenomic data reshapes research & drug discovery

Chronic kidney disease (CKD) presents complex diagnostic and therapeutic challenges due to its heterogeneity and progressive nature. In this webinar, we explore how integrating genetic testing with real-world clinical data is revolutionizing the understanding of kidney disease and unlocking new avenues for targeted drug development.

Join us as we delve into the power of a longitudinal clinicogenomic database purpose-built for kidney disease—capturing genetic variants, clinical outcomes, and patient trajectories over time. Through real-world case studies and emerging research, we'll demonstrate how this integrated approach is enabling earlier and more accurate diagnoses, refining patient identification, and informing precision drug development for CKD.

Attendees will gain insights into:

• The role of genetic testing in diagnosing kidney diseases
• How longitudinal data supports the mapping of individual patient journeys
• Real-world examples illustrating the clinical and translational value of integrated data in CKD

Whether you're a clinical researcher, drug developer, or healthcare innovator, this session offers a front-row look at how clinicogenomic intelligence is shaping the future of kidney care.